Certis Biologicals, Novozymes develop products for corn, soybeans
Summary
“Growers need innovative solutions, and we are proud to be part of bringing those solutions to the marketplace with Novozymes.” “The recent US EPA registration of Novozymes LCO Promoter technologies opens a gateway for new collaborations with innovative, first mover partners like Certis Biologicals,” said Jason Ward, head of North America, BioAg Commercial Operations at Novozymes. Both companies expect that trials, which are taking place in the Midwestern U.S., will begin to yield data in November 2022, ahead of the 2023 growing season. This level of protection in a single solution will consistently deliver value back to the grower.” “Novozymes BioAg has hundreds of trial results across many years and crops documenting LCO Promoter yield increase. LCO is an ideal premix solution delivering consistent yield increases across a wide range of labeled crops, for instance, 4 to 6 bushels in corn. Certis Biologicals biofungicide provides broad-spectrum preventative control or suppression of many fungal and bacterial plant diseases.